Cynthia M Butitta
from San Francisco, CA
Cynthia Butitta Phones & Addresses
- 900 Bush St, San Francisco, CA 94109 • 415 674-5689
- 960 Bush St, San Francisco, CA 94109
- 900 Bush St, San Francisco, CA 94109 • 415 608-1720
Work
-
Position:Personal Care and Service Occupations
Education
-
Degree:Associate degree or higher
Name / Title
Company / Classification
Phones & Addresses
Chief Financial Officer
Timothy David Cole, Telik Inc
Mfg Pharmaceutical Preparations
Mfg Pharmaceutical Preparations
750 Gtwy Blvd, South San Francisco, CA 94080
Resumes
Chief Operations Officer And Chief Financial Officer
view sourceLocation:
Palo Alto, CA
Industry:
Biotechnology
Work:
Kindred Biosciences, Inc.
Chief Operations Officer and Chief Financial Officer
Chief Operations Officer and Chief Financial Officer
Education:
University of Wisconsin - Madison 1976 - 1978
Board Member
view sourceLocation:
San Francisco, CA
Industry:
Biotechnology
Work:
Autolus Ltd.
Board Member
Kite Pharma Dec 1, 2013 - Dec 2017
Chief Operating Officer and Chief Financial Officer
Urogen Pharma Dec 1, 2013 - Dec 2017
Board Member
Nextwave Pharmaceuticals Mar 2011 - Dec 2012
Svp, Chief Financial Officer
Silicon Valley Directors Exchange 2008 - 2010
Board Member
Board Member
Kite Pharma Dec 1, 2013 - Dec 2017
Chief Operating Officer and Chief Financial Officer
Urogen Pharma Dec 1, 2013 - Dec 2017
Board Member
Nextwave Pharmaceuticals Mar 2011 - Dec 2012
Svp, Chief Financial Officer
Silicon Valley Directors Exchange 2008 - 2010
Board Member
Education:
University of Wisconsin - Madison 1976 - 1978
Master of Business Administration, Masters, Finance Edgewood College 1972 - 1976
Bachelors, Bachelor of Science, Business, Accounting Santa Clara University
Bachelors, Bachelor of Arts
Master of Business Administration, Masters, Finance Edgewood College 1972 - 1976
Bachelors, Bachelor of Science, Business, Accounting Santa Clara University
Bachelors, Bachelor of Arts
Skills:
Strategy
Mergers and Acquisitions
Business Development
Cross Functional Team Leadership
Finance
Strategic Planning
Start Ups
Venture Capital
Mergers
Ipo
Business Planning
Biotechnology
Leadership
Sec Filings
Strategic Financial Planning
Medical Devices
Business Strategy
Investor Relations
Accounting
Executive Management
Acquisition Integration
Corporate Development
Financial Modeling
Sarbanes Oxley Act
Management
Financial Planning
Mergers and Acquisitions
Business Development
Cross Functional Team Leadership
Finance
Strategic Planning
Start Ups
Venture Capital
Mergers
Ipo
Business Planning
Biotechnology
Leadership
Sec Filings
Strategic Financial Planning
Medical Devices
Business Strategy
Investor Relations
Accounting
Executive Management
Acquisition Integration
Corporate Development
Financial Modeling
Sarbanes Oxley Act
Management
Financial Planning
Cynthia Butitta
view sourceNews
Kite Pharma Takes Cue From Battle Between Gilead (GILD), AbbVie (ABBV)
view source- Cynthia Butitta, Chief Financial Officer for Kite stated that the price tag for a single treatment is expected to be set at $150,000; however, the actual price could change depending upon the results of clinical trials, and the safety and efficacy profile of the treatment. The price tag for the trea
- Date: Jan 16, 2015
- Category: Business
- Source: Google
Cynthia Butitta
view sourceYoutube
Get Report for Cynthia M Butitta from San Francisco, CA